Kratom Industry Navigates Expanding Regulatory Landscape as Lawmakers Weigh Bans and Guardrails

Kratom Industry Navigates Expanding Regulatory Landscape as Lawmakers Weigh Bans and Guardrails

NATIONAL NEWS BRIEF – The kratom industry is facing an increasingly complex regulatory environment as state lawmakers across the U.S. grapple with how to manage the substance and its potent derivative, 7-hydroxymitragynine (7-OH). A recent report from the National Conference of State Legislatures (NCSL) highlights the growing legislative activity, driven by concerns over product safety, potential for addiction, and the proliferation of unregulated retail sales.

What Happened

Lawmakers nationwide are actively considering a range of policy responses, from outright bans to comprehensive consumer protection frameworks. The debate is fueled by the distinction between traditional kratom, which contains trace amounts of naturally occurring 7-OH, and newer products that often feature synthetically concentrated or chemically modified 7-OH at levels far exceeding what is found in nature.

Federal agencies have also weighed in, with the U.S. Food and Drug Administration (FDA) warning consumers against kratom use and formally recommending that 7-OH be classified as a Schedule I controlled substance. The Drug Enforcement Administration (DEA) has labeled kratom a "drug of concern." These federal advisories have accelerated legislative efforts at the state level.

As of June 2026, at least 31 states and Washington, D.C., have implemented some form of regulation for kratom or its components. State approaches vary widely:

• Bans on Synthetic 7-OH and Age Restrictions: Colorado, for example, enacted a law in 2025 restricting sales to individuals 21 and older, banning synthetic kratom alkaloids, and limiting 7-OH to 2% of total alkaloids. Products appealing to children, combustible forms, or those lacking clear labeling are also prohibited.
• Targeted Prohibitions: Ohio has permanently banned synthetic kratom compounds like 7-OH through pharmacy rulemaking, while still deliberating on natural kratom products. Rhode Island reversed an earlier blanket ban to instead regulate kratom sales while prohibiting 7-OH products entirely.
• Alkaloid Limits and Labeling Requirements: Oklahoma limits 7-OH to 1% of total alkaloids, prohibits synthesized compounds or contaminated products, and mandates detailed labeling of total alkaloids, mitragynine, and 7-OH.
• Outright Bans: Kansas implemented a statewide ban on the sale and possession of kratom and 7-OH, effective July 1, 2026. Suffolk County, New York, recently revised a proposed bill to allow loose leaf kratom but ban pill, capsule, or liquid vial forms, and specifically prohibit synthetic 7-OH, citing concerns about misinformation and misleading labels.

Why It Matters to Kratom Merchants and Consumers

This evolving and fragmented regulatory landscape creates significant challenges for both kratom merchants and consumers. For merchants, navigating a patchwork of state-specific laws, which can even vary by county, requires constant vigilance and adaptability. The increasing focus on synthetic 7-OH and high-potency derivatives means that products with concentrated 7-OH are at a heightened risk of being banned or heavily restricted, impacting product development and inventory management. Consumers, in turn, face inconsistent access to kratom products depending on their location, with some jurisdictions moving towards complete prohibition. Advocacy groups are calling for clear, consistent regulation and enforcement to provide stability for the industry.

Compliance Implications

The regulatory shifts underscore a critical need for robust compliance measures. Merchants must be prepared for:

• Strict Age Verification: Mandatory age limits are becoming more common, necessitating effective age verification systems for all sales channels, especially online.
• Product Composition Scrutiny: Increased examination of product ingredients, particularly the concentration of 7-OH and the presence of synthetic compounds, is now a given.
• Enhanced Labeling Standards: Expect requirements for more detailed and accurate labeling, including specific alkaloid content (mitragynine and 7-OH) and comprehensive product disclaimers.
• Product Form Restrictions: Some jurisdictions are banning specific product forms, such as pills, capsules, or liquid vials, regardless of their content.
• Severe Penalties: Violations can lead to significant penalties, including misdemeanor charges, substantial fines, and even imprisonment.

What High-Risk Merchants Need to Know About COAs, Lab Testing, and Regulatory Compliance

For high-risk kratom merchants, proactive and rigorous compliance is paramount.

1. Mandatory Third-Party Lab Testing and COAs: Independent third-party lab testing and comprehensive Certificates of Analysis (COAs) are no longer just industry best practices; they are becoming a regulatory necessity. Merchants must ensure their products undergo thorough testing for alkaloid profiles, specifically verifying mitragynine and 7-OH content.
2. Adherence to Alkaloid Limits: Crucially, lab tests must confirm that products comply with state-specific limits for 7-OH, such as Oklahoma's 1% or Colorado's 2% of total alkaloids. The absence of synthetic kratom alkaloids must also be verified.
3. Purity and Contamination Checks: Lab testing should extend to screening for contaminants, as several states explicitly prohibit the sale of adulterated or contaminated products.
4. Accurate and Transparent Labeling: Labels must precisely reflect the product's composition as confirmed by COAs, including total alkaloid content, mitragynine, and 7-OH levels, to meet evolving state standards. Misleading labels are a specific concern for lawmakers.
5. Continuous Regulatory Monitoring: The legislative landscape is dynamic. Merchants must establish robust systems to continuously monitor and adapt to new state and local laws in every jurisdiction where they operate or sell.
6. Legal Expertise: Engaging legal counsel specializing in kratom regulation is highly advisable to navigate the intricate and varied compliance requirements effectively.
7. Meticulous Record-Keeping: Maintain comprehensive records of all lab tests, COAs, and internal compliance procedures. This documentation is crucial for demonstrating due diligence and adherence to regulations if scrutinized by authorities.

The trend indicates a move towards more stringent regulation, particularly around concentrated and synthetic 7-OH products. Merchants who prioritize transparency, rigorous testing, and strict adherence to evolving state laws will be best positioned to navigate this challenging environment.